Alexion Pharmaceuticals Inc shows Mean Deviation of 2.34 and Risk Adjusted Performance of 0.087424. Alexion Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Alexion Pharmaceuticals Inc which can be compared to its rivals. Please confirm Alexion PharmaceuticalsStandard Deviation as well as the relationship between Maximum Drawdown and Expected Short fall to decide if Alexion Pharmaceuticals is priced correctly providing market reflects its regular price of 117.1 per share. Given that Alexion Pharmaceuticals has Jensen Alpha of 0.0154, we suggest you validate Alexion Pharmaceuticals Inc prevailing market performance to make sure the company can sustain itself at future point.
The output start index for this execution was fourteen with a total number of output elements of three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Alexion Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.
Alexion Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Alexion Pharmaceuticals Inc. You can use it to identify possible trend reversals for Alexion Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Alexion Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Alexion Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Alexion Pharmaceuticals Inc applied against its price change over selected period. The best fit line has a slop of 0.20 % which means Alexion Pharmaceuticals Inc will continue generating value for investors. It has 34 observation points and a regression sum of squares at 31.17, which is the sum of squared deviations for the predicted Alexion Pharmaceuticals price change compared to its average price change.
Did you try this?
Run Crypto Portfolio Optimizer Now
Crypto Portfolio Optimizer
Optimize portfolio of digital coins and token across multiple currency and exchanges
Alexion Pharmaceuticals Inc is number one stock in mean deviation category among related companies. It is currently under evaluation in standard deviation category among related companies creating about 1.42 of Standard Deviation per Mean Deviation. The ratio of Standard Deviation to Mean Deviation for Alexion Pharmaceuticals Inc is roughly 1.42